Cargando…

Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?

Detalles Bibliográficos
Autores principales:	Naggie, Susanna, Ramers, Christian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442701/ https://www.ncbi.nlm.nih.gov/pubmed/30976736 http://dx.doi.org/10.1002/hep4.1347

Ejemplares similares

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs
por: Brener, L., et al.
Publicado: (2021)

Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy
por: Kutsa, Oksana, et al.
Publicado: (2016)

Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran
por: Nakhaeizadeh, Mehran, et al.
Publicado: (2020)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

People who inject oral morphine favor experimentation with injectable opioid substitution
por: Bertin, Célian, et al.
Publicado: (2023)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
por: Lima, Viviane D., et al.
Publicado: (2015)

First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada
por: Bouck, Zachary, et al.
Publicado: (2023)

Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions
por: Bouck, Zachary, et al.
Publicado: (2022)

Retraction of WHO guidance on opioid use
Publicado: (2020)

Physical pain is common and associated with nonmedical prescription opioid use among people who inject drugs
por: Dahlman, Disa, et al.
Publicado: (2017)

Assisted injection among people who inject drugs in Thailand
por: Lee, William K, et al.
Publicado: (2013)

Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID) infections in persons who inject drugs
por: Lim, Jacqueline, et al.
Publicado: (2022)

HIV among people who inject drugs in Hungary
por: Ortutay, András, et al.
Publicado: (2017)

Estimating the number of people who inject drugs in Australia
por: Larney, Sarah, et al.
Publicado: (2017)

Correlates of 90-Day Mortality Among People Who Do and Do Not Inject Drugs With Infective Endocarditis in Seattle, Washington
por: Corcorran, Maria A, et al.
Publicado: (2022)

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
por: Ferraro, Claire F., et al.
Publicado: (2021)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Psychiatric Comorbidity, Psychosocial Problems, and Functioning of People Who Inject Opioids: An Observational Study
por: Farooqui, Azhar Mahmood, et al.
Publicado: (2022)

Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993–2007
por: Tempalski, Barbara, et al.
Publicado: (2018)

HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
por: Fotiou, Anastasios, et al.
Publicado: (2016)

HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade
por: Cholette, François, et al.
Publicado: (2020)

Symposium Title: Opioid Overdose Among People Who Inject Drugs – Findings from two Delhi-based studies
por: Rao, Ravindra, et al.
Publicado: (2022)

Commentary: the value of PrEP for people who inject drugs
por: Coleman, Rosalind L, et al.
Publicado: (2016)

No significant HTLV seroprevalence in German people who inject drugs
por: Hohn, Oliver, et al.
Publicado: (2017)

Caring for people who inject drugs when they are admitted to hospital
por: Brothers, Thomas D., et al.
Publicado: (2021)

Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993–2007
por: Tempalski, Barbara, et al.
Publicado: (2020)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Evidence-Based Prevention Interventions for People Who Use Illicit Drugs
por: Kresina, Thomas F., et al.
Publicado: (2013)

Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study
por: Palmer, Anna, et al.
Publicado: (2020)

Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020)

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
por: Schwarz, M., et al.
Publicado: (2023)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

COVID-19 and people who use drugs; seizing opportunity in times of chaos
por: Wisse, Ernst, et al.
Publicado: (2021)

Enough is enough
por: Borowski, Christine
Publicado: (2011)

An Overview of HIV Prevention Interventions for People Who Inject Drugs in Tanzania
por: Ratliff, Eric A., et al.
Publicado: (2013)

HIV Test Avoidance Among People Who Inject Drugs in Thailand
por: Ti, Lianping, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3pvef5fka6ubuifls3p9rm0kma